Exelixis
EXEL
131 hedge funds and large institutions have $1.44B invested in Exelixis in 2013 Q4 according to their latest regulatory filings, with 21 funds opening new positions, 37 increasing their positions, 42 reducing their positions, and 15 closing their positions.
68% more call options, than puts
Call options by funds: $10M | Put options by funds: $5.98M
44% more capital invested
Capital invested by funds: $1B → $1.44B (+$435M)
40% more first-time investments, than exits
New positions opened: 21 | Existing positions closed: 15
4% more funds holding
Funds holding: 126 → 131 (+5)
12% less repeat investments, than reductions
Existing positions increased: 37 | Existing positions reduced: 42
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$12.1M |
| 2 |
HM
HealthCor Management
New York
|
+$10.2M |
| 3 |
Fidelity Investments
Boston,
Massachusetts
|
+$4.47M |
| 4 |
O
OrbiMed
New York
|
+$3.55M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$1.72M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BI
BVF Inc
San Francisco,
California
|
-$14.6M |
| 2 |
MG
Meditor Group
Hamilton,
Bermuda
|
-$8.08M |
| 3 |
State Street
Boston,
Massachusetts
|
-$4.18M |
| 4 |
Jennison Associates
New York
|
-$2.28M |
| 5 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$1.59M |
EXEL Hedge Fund Activity: Q4 2013 in Review
131 of the 3,459 institutional investors tracked by Wall St. Rank reported a position in Exelixis (EXEL) for Q4 2013, worth a combined $1.44B — up 44% from $1B a quarter earlier.
Buyers outnumbered sellers: 21 funds opened new EXEL positions and 15 closed out — a net gain of 6 holders — while 37 added to existing stakes and 42 trimmed.
The largest buyer was T. Rowe Price Associates, adding an estimated $12.1M. The largest seller was BVF Inc, exiting entirely with an estimated $14.6M sold.
- 131 institutional investors held Exelixis (EXEL) as of Q4 2013, up from 126 in Q3 2013.
- Funds reported $1.44B of Exelixis stock for Q4 2013, up 44% quarter-over-quarter.
- 21 funds opened new Exelixis positions in Q4 2013 and 15 closed out, a net change of +6 holders.
- The largest Exelixis buyer in Q4 2013 was T. Rowe Price Associates, an estimated $12.1M added.
- The largest Exelixis seller in Q4 2013 was BVF Inc, an estimated $14.6M sold.
Based on aggregated 13F filings for Q4 2013.